Neurology
2 drugs are in development for Ischemic Stroke.
- Companies
- 2
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ischemic Stroke pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| MSC | Accustem Sciences Inc. (ACUT) |
Preclinical(1)
| Drug | Company |
|---|---|
| BXT-25 | BIOXYTRAN, INC (BIXT) |
About this indication
Ischemic Stroke context
Neurology·MeSH: Ischemic Stroke (D000083242)
Also known as: Ischaemic Strokes, Ischemic Strokes, Stroke, Ischaemic
Narrower concepts tracked separately: Acute Ischemic Stroke, Ischemic Stroke, Acute
Prevalence
1008.3 / 100K
Incidence
109.6 / 100K/yr
Frequently asked questions
How many drugs are in development for Ischemic Stroke?
BioSniper tracks 2 drugs in development for Ischemic Stroke across 2 companies.
How many clinical trials target Ischemic Stroke?
There are 19 clinical trials targeting Ischemic Stroke tracked by BioSniper.
What is the prevalence of Ischemic Stroke?
The estimated prevalence of Ischemic Stroke is approximately 1008.3 per 100,000 population.